Robert N. Muller

VSION as high field MRI T1 contrast agent: evidence of their potential as positive contrast agent for magnetic resonance angiography

S. Boutry, D. Stanicki, T. Vangijzegem, 2018, Nanotechnology.

Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death.

V. Grégoire, S. Laurent, R. Muller, 2010, Contrast media & molecular imaging.

Iron oxide based MR contrast agents: from chemistry to cell labeling.

S. Laurent, L. Vander Elst, R. Muller, 2009, Current medicinal chemistry.

HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies

P. Delvenne, P. Peixoto, A. Blomme, 2016, Oncogene.

How to measure the transmetallation of a gadolinium complex.

S. Laurent, L. Vander Elst, R. Muller, 2010, Contrast media & molecular imaging.

Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer’s Disease

L. Vander Elst, C. Burtea, J. De Winter, 2023, Journal of Alzheimer's disease reports.